emmprin
origin
describ
induc
express
mmp
gain
attent
involv
variou
immunolog
diseas
antiemmprin
antibodi
consid
potenti
therapeut
medic
given
mmp
involv
pathogenesi
variou
diseas
state
relev
target
upstream
induc
would
make
effect
therapeut
strategi
addit
emmprin
appreci
multipl
role
apart
mmp
induct
includ
cellular
function
migrat
adhes
invas
energi
metabol
well
cell
activ
prolifer
review
known
emmprin
numer
immunologicinflammatori
diseas
condit
particular
focu
complex
role
cell
biolog
j
leukoc
biol
abbrevi
defici
alanineserinecystein
transport
reg
activ
regulatori
cell
bbb
blood
brain
barrier
c
constant
cia
collageninduc
arthriti
cypab
cyclophilin
ab
dn
doubl
neg
dp
doubl
posit
eae
experiment
autoimmun
encephalomyel
ec
extracellular
ecm
extracellular
matrix
emmprin
extracellular
matrix
metalloproteinas
induc
fl
fibroblastlik
synoviocyt
continu
next
page
continu
previou
page
forkhead
box
gvhd
graftversushost
diseas
hcc
hepatocellular
carcinoma
hypoxiainduc
factor
hspg
heparin
sulfat
proteoglycan
intermedi
ltype
amino
acid
transport
lck
lymphocytespecif
protein
tyrosin
kinas
mct
monocarboxyl
transport
mmp
matrix
metalloproteinas
mog
myelin
oligodendrocyt
glycoprotein
ms
multipl
sclerosi
membran
type
ra
rheumatoid
arthriti
rt
reg
rest
regulatori
cell
sirna
small
interf
rna
sle
system
lupu
erythematosu
sp
singl
posit
tm
transmembran
reg
regulatori
cell
v
variabl
vegf
vascular
endotheli
growth
factor
emmprin
cellsurfaceglycosyl
tm
protein
belong
ig
superfamili
first
discov
lung
cancer
cell
line
stimul
product
collagenas
adjac
fibroblast
cell
thu
first
design
tumor
cellderiv
collagenas
stimulatori
factor
name
includ
basigin
although
studi
extens
tumor
biolog
role
emmprin
normal
cell
function
diseas
state
investig
emmprin
level
upregul
andor
involv
diseas
includ
lunginjuri
model
ischem
myocardi
injuri
atherosclerosi
cancer
sle
gvhd
ra
ms
pathogen
invas
among
insult
review
introduc
biochemistri
emmprin
evalu
multipl
function
cell
discuss
role
immunolog
disord
emmprin
aa
tm
protein
nonglycosyl
molecular
weight
kda
glycosyl
molecular
weight
approxim
rang
kda
glycosyl
pattern
may
vari
differ
organ
cell
type
may
reason
multipl
physiolog
role
structur
emmprin
consist
heavili
glycosyl
ec
domain
tm
domain
short
cytoplasm
tail
fig
isoform
emmprin
differ
ec
domain
ec
domain
promin
isoform
forward
call
emmprin
compris
iglik
loop
held
togeth
disulfid
bond
fig
sequenc
analys
crystal
structur
emmprin
demonstr
ntermin
portion
structur
resembl
bstrand
pattern
c
region
ig
particularli
fold
subclass
structur
featur
v
region
ig
addit
c
region
ctermin
loop
slightli
longer
show
strong
homolog
v
region
ig
thu
term
shorten
vset
fold
iset
emmprin
uniqu
among
ig
domain
high
degre
homolog
v
region
ig
well
mhcii
b
chain
contain
c
region
reason
suggest
emmprin
ig
domain
may
primordi
form
ig
superfamili
arrang
ec
portion
emmprin
also
distinct
among
ig
follow
vic
arrang
undergo
vv
ii
dimer
instead
ec
domain
emmprin
appear
undergo
dimer
base
crystal
structur
infer
ig
superfamili
encompass
divers
group
receptor
known
contain
domain
share
evolutionari
homolog
identifi
associ
function
adhes
migrat
cell
recognit
cell
activ
emmprin
clearli
exemplifi
mention
complex
emmprin
term
variou
glycosyl
pattern
type
homoheterophil
interact
domain
contribut
multifunct
natur
rare
isoform
also
exist
express
retina
compris
iglik
loop
name
rare
less
understood
variant
includ
compris
iglik
loop
ec
domain
slightli
extend
interestingli
found
act
inhibitor
emmprin
like
heterooligomer
demonstr
hcc
cell
contrast
overexpress
inhibit
cellular
prolifer
mmp
induct
invas
highli
conserv
glutam
acid
residu
leucin
zipper
found
tm
domain
hypothes
interact
number
yetunidentifi
protein
plasma
membran
although
cytoplasm
tail
short
aa
rule
involv
emmprin
initi
variou
signal
pathway
even
coreceptor
tm
cytoplasm
domain
highli
conserv
among
speci
thu
emphas
critic
function
role
region
emmprin
kda
solubl
form
emmprin
shed
cell
surfac
cleav
first
iglik
domain
addit
fulllength
emmprin
releas
cell
via
microvesicl
shed
effici
vehicl
elicit
commun
cell
reason
outward
bud
emmprincontain
microvesicl
plasma
membran
tumor
cell
shortli
break
apart
give
rise
membran
fragmentassoci
emmprin
ec
space
solubl
form
microvesicleassoci
form
primarili
induc
mmp
activ
stromal
cell
sinc
studi
describ
involv
emmprincontain
microvesicl
aspect
angiogenesi
migrat
invas
cancer
cell
domain
emmprin
identifi
interact
differ
protein
correspond
particular
function
mab
toward
emmprin
may
alter
function
without
affect
anoth
importantli
nlink
glycosyl
asparagin
residu
homophil
interact
signific
function
protein
interact
emmprin
demonstr
purifi
deglycosyl
emmprin
fail
induc
activ
tumor
cell
domain
emmprin
import
mmp
induct
well
oligomer
bind
integrin
like
singl
tm
glycoprotein
involv
adhes
amino
acid
transport
fig
domain
describ
bind
cyclophilin
import
chemotaxi
adhes
neg
regul
bind
emmprin
low
glycosyl
form
prevent
glycosyl
cluster
cell
surfac
fig
tm
domain
bind
cyclophilin
serv
chaperon
emmprin
cell
surfac
like
involv
interact
adhes
molecul
hspg
involv
adhes
integrin
fig
lastli
tm
cytoplasm
domain
emmprin
interact
mct
wide
express
predominantli
express
retin
pigment
epithelium
emmprin
shuttl
mct
plasma
membran
play
essenti
metabol
role
transport
monocarboxyl
pyruv
lactat
fig
emmprininteract
protein
includ
glycoprotein
vi
involv
platelet
roll
annexin
ii
implic
cytoskeleton
rearrang
influenc
cell
invas
gsecretas
complex
implic
alzheim
diseas
product
amyloid
b
peptid
understand
emmprin
function
emmprin
knockout
mice
gener
although
gross
abnorm
observ
histolog
mice
exhibit
neurolog
deficit
associ
decreas
sensit
irrit
odor
figur
emmprin
structur
emmprin
singl
tm
protein
consist
nlink
glycosyl
site
asparagin
residu
asn
ec
region
tm
contain
highli
conserv
glutam
acid
residu
glu
short
cytoplasm
tail
ec
region
broken
iglik
loop
held
togeth
disulfid
bond
domain
emmprin
interact
differ
protein
thu
differ
function
capabl
see
text
detail
c
ctermin
n
ntermin
ss
disulfid
bond
light
result
blind
hypersensit
electr
foot
shock
well
deficit
learn
memori
abnorm
appear
correl
subregion
mous
brain
shown
express
emmprin
abnorm
found
bbb
mutant
mice
even
though
emmprin
express
endotheli
vessel
cn
furthermor
emmprin
appear
involv
earli
embryogenesi
reproduct
emmprin
knockout
mice
rare
born
surviv
small
weak
steril
half
die
within
month
result
interstiti
pneumonia
emmprin
express
wide
varieti
cell
type
vari
level
includ
hematopoiet
epitheli
endotheli
tumor
cell
express
profil
emmprin
transcript
level
show
human
emmprin
highli
express
heart
skelet
muscl
compar
test
organ
like
demonstr
import
metabol
kidney
also
high
express
level
testi
correl
involv
spermatogenesi
hematopoiet
cell
emmprin
express
leukocyt
monocyt
granulocyt
lymphocyt
erythrocyt
platelet
emmprin
upregul
activ
cell
also
shown
recent
serv
marker
reg
emmprin
versu
rt
reg
naiv
reg
emmprin
human
system
furthermor
label
wellknown
intracellular
reg
marker
emmprin
enabl
identif
distinct
popul
emmprin
low
cell
repres
rt
reg
emmprin
medium
cell
repres
reg
produc
cytokin
review
ref
includ
ifng
tnfa
emmprin
high
cell
repres
reg
secret
high
level
cytokin
demonstr
highli
suppress
activ
exhibit
demethyl
reg
specif
demethyl
region
gene
region
whose
demethyl
statu
correl
stabil
express
suppress
activ
unknown
emmprin
play
role
immun
homeostasi
may
serv
use
marker
reg
subset
evalu
diseas
progress
emmprin
first
character
mmp
induc
known
multipl
function
differ
cell
type
includ
cell
evid
support
function
role
emmprin
mani
differ
stage
cell
activ
cell
develop
activ
prolifer
migrat
adhes
invas
fig
step
import
pathogenesi
variou
diseas
interestingli
emmprin
exemplifi
posit
induc
action
negativeregulatori
action
cell
review
detail
known
function
emmprin
cell
biolog
thymu
primari
site
cell
ontogeni
lymphocyt
precursor
develop
yield
matur
cell
upon
entri
thymu
cell
precursor
classifi
dn
thymocyt
surfac
marker
express
first
stage
develop
separ
dn
phase
distinguish
express
fig
tcrb
chain
test
function
dramat
expans
function
pretcr
ensu
mark
end
dn
phase
second
stage
cell
develop
includ
dp
thymocyt
posit
surfac
marker
undergon
gene
rearrang
tcra
chain
express
complet
tcr
complex
select
process
occur
lead
stage
posit
select
cell
yield
sp
thymocyt
neg
select
caus
elimin
potenti
autoreact
cell
apoptosi
fig
emmprin
highli
express
surfac
thymocyt
fig
shown
influenc
matur
wherea
thymocyt
express
emmprin
mean
fluoresc
intens
higher
cell
cycl
particularli
transit
tcrbselect
cell
undergo
prolif
burst
presenc
antiemmprin
antibodi
clone
halt
murin
thymocyt
develop
larg
reduc
level
stage
well
dp
sp
popul
result
corrobor
newli
gener
emmprinflox
mice
emmprin
condit
ablat
cell
use
lckcre
promot
condit
delet
emmprin
lckcreexpress
cell
similar
addit
antiemmprin
antibodi
result
decreas
dp
result
enhanc
apoptosi
sp
cell
signific
drop
thymu
weight
cell
number
also
appar
although
dn
phase
whole
show
alter
emmprin
thymocyt
dn
stage
assess
separ
analyz
differ
stage
cycl
abil
thymocyt
suggest
correl
emmprinexpress
level
reason
assum
emmprin
play
role
dramat
expans
phase
rapid
prolifer
thymocyt
like
undergo
glycolysi
meet
energi
demand
thu
lead
buildup
toxic
intracellular
lactat
level
way
possibl
emmprin
need
chaperon
shuttl
mct
surfac
export
toxic
lactat
buildup
cell
absenc
emmprin
would
hinder
export
possibl
lead
cell
death
altern
metabol
pathway
evid
illustr
emmprin
play
role
cell
activ
prolifer
howev
seem
display
differ
function
respons
particular
phase
cell
activ
emmprin
level
high
thymocyt
fig
level
peripheri
rest
cell
low
fig
becom
upregul
upon
cell
activ
fig
demonstr
emmprin
neg
regulatesinhibit
cell
prolifer
mlr
splenocyt
emmprin
anim
exhibit
enhanc
prolif
respons
compar
wildtyp
splenocyt
cocultur
irradi
balbc
splenocyt
similar
respons
observ
emmprin
cell
lckcre
figur
role
emmprin
cell
biolog
emmprin
involv
cell
develop
activ
prolifer
migrat
invas
adhes
energi
metabol
highli
express
thymocyt
cell
develop
play
role
transit
phase
prolif
burst
occur
peripheri
emmprin
express
level
low
local
immun
synaps
upon
tcrmediat
cell
activ
tcrmhc
engag
lead
upregul
ligand
signal
allow
costimul
signal
apc
also
express
emmprin
may
act
altern
costimul
provid
signal
cell
activ
emmprin
interact
number
molecul
regul
adhes
see
fig
could
play
role
immun
synaps
format
b
cell
activ
emmprin
level
upregul
involv
number
action
c
see
text
detail
mhc
major
histocompat
complex
emmprin
floxflox
mice
also
reveal
elev
level
earli
cell
activ
marker
rest
state
spleen
weight
proport
express
level
differ
emmprin
cell
control
human
system
knockdown
emmprin
use
sirna
primari
cell
also
increas
cell
prolifer
without
chang
express
upon
activ
pha
surfac
receptor
crosslink
result
demonstr
emmprin
negativeinhibitori
effect
cell
activ
contrast
numer
studi
use
antibodi
emmprin
eg
clone
clone
shown
antibodi
suppress
cell
prolifer
human
pbmc
suggest
antiemmprin
antibodi
may
act
agonist
mimick
ligand
engag
interestingli
emmprin
cell
antiemmprin
antibodi
alter
prolifer
cell
stimul
pma
ionomycin
stimul
bypass
need
surfac
receptor
impli
emmprin
involv
earli
stage
cell
activ
involv
tcr
costimul
minut
tcrdepend
activ
emmprin
aggreg
immun
synaps
fig
area
form
upon
cell
activ
dens
pack
receptor
signal
molecul
pivot
initi
cell
activ
emmprin
coloc
immun
synaps
marker
includ
wherea
presenc
antiemmprin
antibodi
clone
alter
format
immun
synaps
administr
clone
upon
tcrmediat
activ
displac
cell
coreceptor
lipid
raft
lead
reduc
express
cell
activ
marker
henc
reduc
cell
prolifer
transcript
ifng
among
cytokin
hour
activ
also
diminish
howev
microdomain
affect
antibodi
distribut
pattern
lck
chang
tyrosin
phosphoryl
level
minut
activ
well
level
hour
activ
anoth
emmprin
antibodi
clone
dock
domain
emmprin
similar
contrast
effect
clone
recogn
domain
upon
tcrmediat
activ
human
cell
clone
demonstr
reduc
protein
level
howev
clone
also
decreas
tyrosin
phosphoryl
hour
activ
ec
calcium
influx
protein
level
addit
increas
ifng
protein
level
hour
activ
differ
antibodi
respons
could
result
differ
experiment
method
eg
time
analyz
cell
activ
perhap
result
differ
function
domainsepitop
emmprin
antibodi
recogn
bind
tabl
antibodi
act
agonist
suggest
inhibitori
effect
emmprin
upon
tcrdepend
activ
work
trigger
dissoci
certain
molecul
microdomain
help
shut
cell
respons
mechan
behind
involv
emmprin
cell
activ
still
need
defin
clearli
mab
toward
emmprin
demonstr
addit
differ
mous
antiemmprin
mab
clone
abl
inhibit
migrat
cell
monocyt
toward
cypa
reduc
diseas
sever
mous
model
ra
lung
inflamm
see
section
howev
antibodi
unabl
inhibit
prolifer
mogprim
cell
inhibit
releas
cocultur
fibroblast
mous
macrophag
contrast
antiemmprin
clone
abl
inhibit
secret
novel
antiemmprin
antibodi
clone
suppress
eae
diseas
activ
inhibit
cell
prolifer
well
product
also
observ
emmprin
mab
induc
cell
aggreg
eg
cell
abl
inhibit
cell
prolifer
human
cell
vice
versa
eg
summari
differ
antibodi
discuss
review
affect
activ
emmprin
outlin
tabl
evid
also
suggest
emmprin
may
act
altern
costimulatori
molecul
cell
activ
prolifer
requir
initi
event
signal
provid
tcr
engag
costimulatori
event
signal
fig
studi
suggest
emmprin
express
apc
rather
cell
may
import
allow
cell
prolifer
demonstr
signal
provid
stimul
prolifer
cell
mix
irradi
signal
cell
prepuls
antiemmprin
antibodi
clone
cell
human
monoblastoid
cell
line
lack
fig
thu
depend
altern
costimulatori
pathway
provid
signal
result
confirm
identifi
emmprin
one
candid
gene
involv
chines
hamster
ovari
dendrit
cell
mediat
costimul
cell
implic
emmprin
apc
cell
may
act
import
costimulatori
molecul
cell
activ
yet
studi
also
demonstr
prolif
inhibit
antiemmprin
antibodi
use
clone
purifi
cell
well
pbmc
impli
emmprin
express
apc
well
cell
import
implic
cell
activ
cell
activ
emmprin
level
elev
emmprin
evolv
positiveinduc
cell
action
action
migrat
mmp
induct
adhes
energi
metabol
activ
discuss
section
reduc
absenc
emmprin
even
upon
administr
certain
antibodi
emmprin
fig
emmprin
play
role
recruit
cell
inflam
tissu
emmprin
identifi
main
receptor
ec
cypa
chemotact
factor
leukocyt
fig
cyclophilin
abund
intracellular
protein
known
bind
immunosuppress
drug
cyclosporin
howev
report
cyclophilin
releas
ec
space
inflam
tissu
synovi
fluid
patient
ra
sepsi
vascular
smooth
muscl
cell
diseas
import
cypaemmprin
interact
recruit
leukocyt
neutrophil
eosinophil
human
immun
synaps
format
upon
tcrmediat
activ
cell
prolifer
pbmc
purifi
cell
cytokin
express
upon
tcrmediat
activ
cell
effect
tyrosin
phosphoryl
level
pathogen
invas
mening
malaria
immun
synaps
format
upon
tcrmediat
activ
cell
prolifer
purifi
cell
tyrosin
phosphoryl
calcium
influx
level
increas
ifng
tyrosin
phosphoryl
level
tcrstimul
cell
sle
patient
healthi
patient
affect
mmp
activ
inhibit
cell
prolifer
induc
cell
aggreg
tcrmediat
prolifer
cell
preexpos
myeloid
cell
cocultur
cell
aggreg
adhes
jurkat
cell
inhibit
prolifer
purifi
cell
andor
nonimmunosuppress
cyclosporin
analog
mous
model
acut
lung
inflamm
asthmat
inflamm
ra
via
cia
emmprindepend
migrat
activ
cell
also
demonstr
human
system
antiemmprin
antibodi
inhibit
cypamedi
migrat
migrat
stimul
rant
addit
cypa
emmprin
receptor
cypb
induc
chemotaxi
cell
vitro
compar
rant
thu
therapeut
target
cyclophilinemmprin
interact
inflammatori
diseas
may
futur
possibl
mmp
induct
requir
cell
invad
basement
membran
drive
diseas
pathogenesi
thu
way
inhibit
mmp
product
critic
shown
produc
pbmc
cultur
upon
cell
activ
suppress
administr
emmprin
mab
clone
patient
cell
lymphoma
emmprin
found
highli
express
peripher
blood
cell
compar
healthi
control
biopsi
skin
invas
demonstr
infiltr
cell
lymphoma
region
fibroblast
moreov
activityblock
peptid
emmprin
correspond
domain
inhibit
product
experi
use
transform
lymphocyt
cocultur
emmprinneg
fibroblast
anoth
group
also
demonstr
increas
mmp
express
human
cell
line
presenc
fibronectin
thu
cell
high
level
emmprin
may
facilit
invas
via
mmp
induct
contact
fibroblast
substrat
fig
number
adhes
molecul
associ
emmprin
cell
surfac
import
cellcel
contact
event
antigen
present
enter
site
inflamm
erythrocyt
emmprin
appear
function
adhes
molecul
administr
f
fragment
antiemmprin
antibodi
clone
inhibit
migrat
murin
erythrocyt
spleen
circul
caus
anemia
platelet
emmprin
interact
shown
involv
roll
likewis
jurkat
cell
tlymphoma
cell
line
sirnamedi
knockdown
emmprin
reduc
adhes
fibronectin
noteworthi
emmprin
oligomer
import
increas
avid
emmprin
interact
molecul
variou
function
purpos
fig
coimmunoprecipit
immunofluoresc
experi
demonstr
interact
emmprin
like
later
fashion
b
b
integrin
b
b
integrin
membran
site
cellcel
contact
cell
line
fig
cypb
emmprin
ligand
along
glycosaminoglycan
shown
play
role
adhes
human
pbmc
mainli
phenotyp
ecm
furthermor
hspg
present
cell
surfac
cell
also
associ
emmprin
like
tm
region
involv
adhes
fibronectin
via
cypbinduc
mapk
activ
fig
anoth
report
identifi
emmprin
complex
integrin
cypb
human
promonocyt
leukemia
cell
line
mediat
cell
adhes
fibronectin
fig
bind
cypb
thought
catalyz
peptidylprolyl
cistran
isomeras
activ
emmprin
trigger
intracellular
signal
event
induc
cell
aggreg
integrinmedi
adhes
kinas
cdmapk
pathway
propos
regul
integrin
affin
report
coimmunoprecipit
b
integrin
pbmc
complex
also
shown
exist
human
breast
adenocarcinoma
cell
line
fig
besid
metabol
role
cell
best
establish
function
adhes
capabl
addit
presenc
mab
toward
emmprin
clone
activ
human
pbmc
report
reduc
integrin
nfkb
signal
leav
akt
mapk
signal
unaffect
clone
decreas
cell
adhes
endotheli
cell
addit
variou
emmprin
mab
alon
monocyt
cell
line
would
initi
homotyp
cell
aggreg
via
integrin
human
jurkat
cell
leukemia
cell
line
emmprin
mab
andor
also
induc
homotyp
aggreg
adhes
ligand
adhes
also
regul
presenc
adhes
molecul
repres
emmprin
coloc
togeth
site
cellcel
contact
howev
distinct
complex
emmprin
exist
base
coimmunoprecipit
experi
fig
sialoglycoprotein
highli
glycosyl
contain
net
neg
charg
thu
like
abl
repuls
cell
contact
import
cell
migrat
still
permit
cell
contact
first
place
probabl
interact
emmprin
may
inhibit
adhes
capabl
moreov
shown
recent
presenc
antiemmprin
antibodi
alon
jurkat
cell
primari
cell
cell
aggreg
increas
time
wherea
cypainduc
chemotaxi
decreas
result
impli
function
tradeoff
emmprin
interestingli
knock
emmprin
jurkat
cell
rna
interfer
also
induc
cell
aggreg
decreas
level
surpris
emmprin
thought
mediat
adhes
clearli
emmprin
express
level
link
specul
emmprin
may
inhibit
cell
aggreg
addit
antiemmprin
antibodi
may
work
inhibit
emmprin
carri
particular
neg
role
thu
act
antagonist
instead
agonist
even
though
emmprin
shown
involv
adhes
demonstr
paragraph
differ
adhes
complex
like
exist
treatment
emmprin
mab
may
caus
rearrang
adhes
complex
emmprin
seem
influenc
adhes
abil
promin
cell
integrin
b
well
import
antigen
present
adhes
cell
endotheli
cell
upon
entri
site
inflamm
fig
figur
emmprin
interact
emmprin
interact
wide
rang
bind
partner
form
oligom
increas
avid
interact
partner
andor
homotyp
interact
cell
allow
mmp
induct
emmprin
interact
integrin
b
ec
cyclophilin
cypab
may
bind
isomer
emmprin
hspgdepend
fashion
like
trigger
intracellular
signal
event
allow
migrat
andor
integrinmedi
adhes
upon
cell
activ
increas
emmprin
oligomer
allow
cypa
bind
without
need
hspg
cypb
associ
interact
heparin
sulfat
ec
region
emmprin
c
emmprin
also
interact
like
via
ec
region
emmprin
integrin
interestingli
supercomplex
exist
demonstr
involv
regul
emmprinmedi
adhes
energi
metabol
e
competit
bind
emmprin
affect
adhes
capabl
cell
f
lastli
supercomplex
shown
import
energi
metabol
drug
resist
cell
import
adhes
migrat
g
c
distinct
complex
adhes
molecul
may
posit
neg
role
cell
adhes
clariti
still
need
understand
role
emmprin
cellular
adhes
influenc
rapid
rate
cell
prolifer
requir
cell
undergo
glycolysi
instead
oxid
phosphoryl
meet
fastpac
energi
demand
although
glycolysi
gener
energi
faster
oxid
phosphoryl
less
effici
approach
lead
accumul
lactic
acid
byproduct
cancer
alter
energi
metabol
known
warburg
effect
effect
emmprin
appear
regul
mention
previous
emmprin
import
player
allevi
toxic
buildup
lactic
acid
cancer
shuttl
lactat
transportersmctsup
plasma
membran
silenc
emmprin
pancreat
breast
cancer
cell
inhibit
express
reduc
growth
decreas
glycolyt
rate
lactat
efflux
supercomplex
neutral
amino
acid
transport
shown
exist
human
fibrosarcoma
colorect
adenocarcinoma
breast
adenocarcinoma
cell
line
demonstr
import
cellular
metabol
fig
moreov
complex
exist
human
breast
adenocarcinoma
cell
line
fig
said
lactat
transport
also
import
lymphocyt
activ
inhibit
interact
partner
emmprin
cell
activ
inhibit
cell
prolifer
lactat
efflux
thu
emmprin
may
play
role
allevi
toxic
lactic
acid
byproduct
rapid
prolifer
cell
fig
area
requir
investig
emmprin
upregul
number
differ
cancer
level
correl
poor
prognosi
cancer
patient
mmp
identifi
potenti
therapeut
target
cancer
long
time
thu
emmprin
mmpinduc
becom
recogn
suitabl
candid
therapeut
intervent
emmprin
shown
promot
multipl
stage
tumor
progress
tumor
cell
prolifer
invas
metastasi
via
mmp
induct
angiogenesi
stimul
vegf
product
via
pathway
anchorageindepend
growth
chemoresist
lactat
efflux
see
section
energi
metabol
posit
role
emmrin
tumor
growth
biolog
group
explor
understand
benefit
use
antiemmprin
antibodi
potenti
tumor
therapi
includ
hcc
licartin
head
neck
cancer
cnto
clone
relat
cell
biolog
glycosyl
emmprin
highli
express
jurkat
cell
compar
normal
human
pbmc
silenc
emmprin
jurkat
cell
decreas
prolifer
migrat
adhes
fibronectin
emphas
import
emmprin
surviv
growth
cancer
cell
note
absenc
emmprin
primari
cell
led
hyperprolifer
contradictori
result
explain
prolifer
cancer
cell
act
mechan
depend
tcrmediat
signal
event
case
primari
cell
jurkat
cell
cocultur
superantigenload
raji
b
cell
thu
subject
conjug
format
emmprin
aggreg
cell
immun
synaps
jurkat
cell
also
stimul
antibodi
initi
tcrdepend
signal
event
contrari
tcrindepend
mechan
emmprin
overexpress
inhibit
cell
activ
demonstr
nfat
inhibit
essenti
transcript
factor
cell
activ
wherea
emmprin
knockdown
promot
nfat
signal
activ
event
umpir
intracellular
domain
emmprin
inhibitori
effect
emmprin
tcrmediat
activ
jurkat
cell
occur
downstream
guanin
nucleotid
exchang
factor
rasrel
botulinum
toxin
substrat
signal
pathway
upstream
jnk
serinethreonineprotein
kinas
pathway
erk
signal
remain
unaffect
besid
signal
function
activ
prolifer
howev
assess
support
tcrmediat
activ
bring
regulatori
inhibitori
effect
emmprin
earli
stage
cell
activ
howev
tcrindepend
activationprolifer
found
cancer
cell
lymphoma
activ
autoimmun
cell
sle
emmprin
highli
upregul
compar
rest
primari
cell
may
act
posit
stimulatori
manner
activ
adhes
invas
migrat
aid
warburg
effect
sle
system
autoimmun
diseas
associ
abnorm
b
cell
function
lead
dysfunct
number
organ
report
cell
pbmc
sle
patient
hyperactiv
secret
enhanc
level
compar
healthi
control
later
shown
enhanc
secret
activ
correl
enhanc
emmprin
express
cell
patient
applic
antiemmprin
antibodi
clone
reduc
tyrosin
phosphoryl
level
cell
sle
patient
although
affect
mmp
activ
possibl
administr
antiemmprin
antibodi
clone
could
reduc
mmp
activ
dampen
cell
respons
emmprin
mab
could
use
therapeut
strategi
sle
howev
studi
requir
valid
approach
individu
requir
transplant
stem
cell
bone
marrow
cell
form
tissu
graft
therapi
suppress
immun
system
taken
prevent
transplant
donor
cell
attack
recipi
complic
known
gvhd
despit
immunotherapi
steroid
usual
firstlin
treatment
acut
gvhd
still
persist
fair
percentag
case
mani
die
frequent
infect
thu
need
altern
secondari
therapi
phase
clinic
trial
use
abxcbl
also
known
gavilimomab
igm
mab
recogn
emmprin
treatment
steroidresist
acut
gvhd
shown
encourag
result
abxcbl
recogn
emmprin
upregul
activ
b
cell
well
rest
activ
monocyt
dendrit
cell
deplet
cell
popul
though
complementmedi
mechan
rest
lymphocyt
express
low
level
emmprin
shown
remain
unaffect
vitro
report
patient
experi
myalgia
manag
narcot
addit
phase
multicenterrandom
clinic
trial
abxcbl
complet
steroidresist
acut
gvhd
show
abxcbl
well
toler
similar
respons
rate
gain
food
drug
administr
approv
respons
improv
compar
antithymocyt
globulin
altern
secondlin
therapi
inde
abxcbl
show
activ
good
toler
thu
potenti
futur
treatment
inflammatori
diseas
combin
treatment
emmprin
induc
mmp
product
factor
lead
cartilag
bone
destruct
role
investig
ra
emmprin
upregul
rheumatoid
synovi
membran
express
found
correl
product
synovi
tissu
inde
emmprin
involv
pathogenesi
ra
administr
antiemmprin
antibodi
clone
anim
model
suppress
develop
cia
reduc
joint
inflamm
peripher
blood
ra
patient
monocyt
macrophag
show
increas
express
emmprin
compar
healthi
control
increas
synovi
fluid
antiemmprin
antibodi
emmprin
antagonist
peptid
prevent
cypamedi
chemotaxi
mononuclear
cell
well
product
invas
properti
human
fibroblast
cocultur
monocyt
fl
ra
patient
also
possess
high
emmprin
express
level
emmprin
antagonist
peptid
inhibit
product
activ
mmp
well
invas
potenti
cocultur
human
monocyt
cell
demonstr
potenti
therapeut
role
antiemmprin
antibodi
prevent
ra
progress
elev
express
emmprin
found
neutrophil
peripher
blood
ra
patient
compar
control
also
shown
play
role
neutrophil
chemotaxi
via
cypa
antiemmprin
antibodi
prevent
mmp
product
activ
invas
capabl
ra
fl
cocultur
ra
neutrophil
addit
mmp
induct
group
demonstr
involv
emmprin
induct
vegf
human
ra
fl
thu
contribut
angiogenesi
diseas
progress
antiemmprin
antibodi
treatment
sever
combin
immunodefici
mous
model
ra
decreas
express
vegf
improv
outcom
involv
mmp
induct
angiogenesi
ra
emmprin
mab
seem
like
promis
therapi
even
report
stronger
antiangiogen
effect
infliximab
agent
approv
ra
treatment
ms
immunemedi
disord
cn
character
gener
autoreact
cell
demyelin
axon
degener
standard
diseasemodifi
treatment
immunomodul
emmprin
found
upregul
leukocyt
activ
lesion
ms
anim
model
eae
emmprin
coloc
cell
macrophag
astrocyt
inflammatori
perivascular
cuff
eae
ms
upregul
associ
increas
mmp
activ
furthermor
administr
antiemmprin
antibodi
clone
clone
reduc
sever
eae
emphas
role
ms
pathogenesi
antiemmprin
antibodi
treatment
reduc
cn
infiltr
number
perivascular
cuff
mmp
activ
vitro
treatment
reduc
adhes
migrat
leukocyt
across
bbb
endotheli
cell
well
cell
neurotox
demonstr
reduc
granzym
b
level
compar
isotyp
control
emmprin
involv
critic
stage
ms
diseas
includ
cell
activ
prolifer
chemotaxi
leukocyt
adhes
migrat
across
bbb
mmp
induct
essenti
enter
brain
parenchyma
neurotox
multifunct
natur
would
make
excel
therapeut
target
atherosclerosi
inflammatori
diseas
vascular
wall
may
lead
acut
myocardi
infarct
diminish
blood
suppli
heart
stroke
diminish
blood
suppli
brain
result
buildup
andor
ruptur
plaqu
insid
arteri
plaqu
consist
accumul
inflammatori
cell
subsequ
product
mmp
may
lead
plaqu
breakdown
surround
cell
death
therebi
worsen
diseas
progress
emmprin
express
patient
acut
myocardi
infarct
found
upregul
circul
monocyt
correl
monocyt
level
plasma
activ
platelet
monocyt
play
pathogen
role
atherosclerosi
demonstr
emmprinemmprin
interact
cocultur
platelet
monocyt
induc
secret
mmp
proinflammatori
tnfa
antiinflammatori
cytokin
monocyt
via
nfkbmediat
pathway
addit
mous
model
myocardi
infarct
demonstr
emmprin
mice
mice
treat
antiemmprin
antibodi
clone
cypa
mice
exhibit
reduc
infarct
size
compar
control
like
consequ
impair
cypamedi
recruit
adhes
monocyt
neutrophil
injur
site
suggest
emmprin
play
role
leukocyt
recruit
mmp
induct
cardiovascular
diseas
thu
target
cyclophilinemmprin
interact
may
therapeut
benefit
howev
balanc
harm
inflammatori
monocyt
benefici
repar
monocyt
involv
mmpdepend
remodel
develop
scar
tissu
must
consid
lung
interstiti
fibrosi
chronic
lung
diseas
result
excess
accumul
ecm
result
scar
thicken
lung
caus
unknown
effect
therapi
emmprin
express
found
increas
murin
human
lung
fibrosi
alveolar
macrophag
epitheli
cell
treatment
antiemmprin
mab
mous
model
lung
interstiti
fibrosi
reduc
clinic
symptom
decreas
macrophag
infiltr
also
discov
macrophag
induc
differenti
emmprindepend
manner
cellular
mechan
behind
current
unknown
may
involv
cytokin
regul
understand
whether
emmprin
involv
regul
cell
inflammatori
diseas
ms
ra
would
signific
emmprin
identifi
recent
receptor
invas
bacteri
parasit
viral
strain
mening
infect
lead
inflamm
membran
surround
cn
caus
associ
vascular
dysfunct
emmprin
express
peripher
brain
endotheli
cell
identifi
import
receptor
initi
invas
bloodborn
meningococci
particularli
meningococc
type
iv
pilu
compon
pile
pilv
express
emmprin
erythrocyt
also
mediat
erythrocyt
invas
plasmodium
falciparum
malaria
parasit
interfer
use
solubl
emmprin
knockdown
antiemmprin
antibodi
success
prevent
pathogen
colon
furthermor
emmprin
also
discov
play
role
host
entri
cypaassoci
cypabound
sever
acut
respiratori
syndrom
coronaviru
addit
role
viral
oncogenesi
antiemmprin
antibodi
show
efficaci
treatment
gvhd
tumorigenesi
model
ra
ms
acut
myocardi
infarct
lung
inflamm
diseas
state
involv
variou
inflammatori
mediat
result
highlight
import
still
uncertain
role
dysregul
emmprin
immun
cell
diseas
pathogenesi
emmprin
could
also
regard
potenti
diagnost
marker
earlystag
diseas
diseas
monitor
cellmedi
inflamm
reli
cascad
event
includ
develop
activ
prolifer
migrat
adhes
step
shown
influenc
emmprin
complex
way
tabl
administr
mab
dampen
cell
function
respons
tabl
differ
emmprin
antibodi
may
target
specif
cell
activ
like
depend
recogn
epitop
eg
antibodi
inhibit
cell
prolifer
induc
cell
aggreg
vice
versa
tabl
target
approach
like
result
less
toxic
sideeffect
use
therapi
requir
improv
understand
emmprin
biolog
relat
epitop
variou
antibodi
recogn
therapeut
implic
appear
emmprin
mab
behav
agonist
stimulatori
role
function
antagonist
inhibitori
functionblock
role
function
exampl
knock
emmprin
primari
cell
led
increas
prolifer
upon
tcrmediat
activ
tabl
impli
emmprin
function
shut
respons
hand
applic
emmprin
mab
decreas
tcrmediat
prolifer
tabl
indic
antibodi
work
agonist
fashion
particular
task
altern
reduct
emmprin
express
rna
interfer
cancer
cell
applic
emmprin
mab
led
reduct
migrat
adhes
energi
metabol
prolifer
via
tcrindepend
mechan
yet
increas
cell
aggreg
like
demonstr
emmprin
work
promot
migrat
adhes
energi
metabol
cell
tcrindepend
prolifer
cancer
cell
function
imped
cell
aggreg
circumst
emmprin
mab
appear
functionblock
attribut
emmprin
involv
inhibit
cell
aggreg
induc
adhes
migrat
prolifer
cancer
cell
clearli
understood
also
demonstr
mab
recogn
eg
eg
domain
similar
effect
dampen
cell
prolifer
tabl
interestingli
also
recogn
domain
emmprin
seem
behav
function
inact
antibodi
howev
effect
cell
diseas
patient
sle
tabl
thu
antibodi
affin
also
play
role
function
differ
antibodi
respons
could
result
number
reason
exampl
mention
dispar
epitop
recognit
antibodi
affin
densiti
emmprin
cell
surfac
could
influenc
antibodi
function
structur
emmprin
may
orient
upon
bind
variou
interact
partner
may
also
influenc
flexibl
linker
domain
emmprin
allow
conform
chang
observ
emmprin
seem
exhibit
function
dualiti
cell
clearli
understood
alreadi
describ
act
regulatori
molecul
upon
initi
stage
tcrmediat
activ
prolifer
like
cell
aggreg
via
tcrindepend
mechan
howev
cell
activ
cell
develop
emmprin
express
level
high
positivefacilitatori
role
display
activ
chemotaxi
mmp
induct
adhes
like
shuttl
lactat
prolifer
cell
one
reconcil
factor
posit
neg
effect
emmprin
cell
appear
level
leukocyt
level
emmprin
high
thymocyt
cell
peripheri
diseas
state
emmprin
facilit
sever
cell
phenotyp
tabl
contrast
emmprin
level
low
circul
cell
peripheri
normal
homeostasi
emmprin
appear
inhibitori
role
cell
activ
prolifer
decreas
dp
sp
popul
lckcre
emmprin
floxflox
thymocyt
decreas
dp
sp
popul
assess
peripheri
negativeinhibitori
role
emmprin
low
emmprin
level
cell
activ
tcrmediat
activ
human
cell
identifi
emmprin
immun
synaps
emmprin
mab
human
cell
upon
tcrmediat
activ
alter
immun
synaps
format
displac
lipid
raft
decreas
tyrosin
phosphoryl
cytokin
prolifer
emmprin
splenocyt
mlr
increas
prolifer
lckcre
emmprin
floxflox
cell
upon
stimul
increas
prolifer
emmprin
sirna
kd
human
cell
pha
activ
increas
prolifer
emmprin
mab
clone
human
pbmc
andor
purifi
cell
upon
tcrmediat
activ
decreas
prolifer
peripheri
positivefacilitatori
role
emmprin
high
emmprin
level
migrat
emmprin
mab
human
cell
decreas
cypamedi
migrat
emmprin
mab
mous
system
decreas
cypamedi
migrat
emmprin
kd
emmprin
mab
inon
jurkat
cell
decreas
transendotheli
migrat
cypamedi
migrat
invas
emmprin
mab
clone
cocultur
mous
mf
fibroblast
human
cell
inhibit
secret
emmprin
activityblock
peptid
cocultur
transform
human
cell
fibroblast
decreas
stimul
adhes
immunoprecipit
coloc
experi
cell
line
identifi
emmprin
interact
integrin
emmprin
mab
human
pbmc
cell
reduc
cypbinduc
perk
adhes
fibronectin
identifi
integrin
complex
emmprin
mab
clone
upon
tcrmediat
activ
human
pbmc
decreas
integrin
level
decreas
adhes
endotheli
cell
emmprin
mab
jurkat
cell
induc
homotyp
cell
aggreg
adhes
ligand
identifi
complex
emmprin
kd
jurkat
cell
reduc
adhes
ecm
fibronectin
induc
homotyp
cell
aggreg
decreas
express
energi
metabol
emmprin
sirna
kd
human
cell
line
decreas
express
efflux
toxic
lactic
acid
byproduct
identifi
mctemmprin
complex
inhibit
human
pbmc
decreas
cell
prolifer
lactat
efflux
prolifer
emmprin
sirna
kd
jurkat
cell
cell
line
decreas
prolifer
positivefacilitatori
role
emmprin
exist
emmprin
express
level
high
negativeinhibitori
role
emmprin
express
level
low
kd
knockdown
mf
macrophag
perk
phosphoryl
erk
inhibitori
role
emmprin
consist
activ
tcrmediat
mechan
conclus
clariti
emmprin
express
level
control
signal
pathway
emmprin
activ
bind
partner
understand
carri
function
necessari
understand
import
emmprin
apc
versu
cell
initi
tcrmediat
cell
activ
also
requir
clarif
emmprin
could
act
unidentifi
coreceptor
novel
costimul
cell
activ
mani
lesson
learn
understand
involv
emmprin
cell
activ
